IMR Press / CEOG / Volume 41 / Issue 1 / DOI: 10.12891/ceog16002014

Clinical and Experimental Obstetrics & Gynecology (CEOG) is published by IMR Press from Volume 46 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.

Open Access Case Report
Marked improvement of pain from long term fibromyalgia with dextroamphetamine sulfate in a woman who failed to improve with conventional pharmacologic treatment
Show Less
1 Cooper Medical School of Rowan University, Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology & Infertility, Camden, NJ
2 Cooper Institute for Reproductive Hormonal Disorders, P.C., Marlton, NJ
3 Philadelphia College of Osteopathic Medicine, Department of Obstetrics And Gynecology, Philadelphia, PA (USA)
Clin. Exp. Obstet. Gynecol. 2014, 41(1), 90–92; https://doi.org/10.12891/ceog16002014
Published: 10 February 2014
Abstract

Purpose: To determine if treatment with the sympathomimetic amine dextroamphetamine sulfate, which has been so effective in treating a variety of pain syndromes, including severe pelvic pain and interstitial cystitis in women with the sympathetic neural hyperalgesia edema syndrome would also mitigate pain from fibromyalgia which was resistant to multiple therapies. Materials and Methods: Dextroamphetamine sulfate extended release capsules once daily was gradually increased to 25mg per day in a woman with treatment resistant fibromyalgia of 20 years duration. Results: Within a short time, the woman experienced dramatic relief of pain. Furthermore, her edema improved resulting in a 27 pound weight loss and her chronic fatigue improved. Conclusions: Fibromyalgia can be effectively treated with an innocuous dose of dextroamphetamine sulfate.
Keywords
Sympathetic nervous system
Fibromyalgia
Sympathomimetic amines
Dextroamphetamine sulfate
Share
Back to top